Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;9(1):100289.
doi: 10.1016/j.esxm.2020.100289. Epub 2021 Jan 8.

Examining Online Traffic Patterns to Popular Direct-To-Consumer Websites for Evaluation and Treatment of Erectile Dysfunction

Joel J Wackerbarth  1 , Richard J Fantus  1 , Annie Darves-Bornoz  2 , Marah C Hehemann  3 , Brian T Helfand  3 , Mary Kate Keeter  2 , Robert E Brannigan  2 , Nelson E Bennett  2 , Joshua A Halpern  4
Affiliations

Examining Online Traffic Patterns to Popular Direct-To-Consumer Websites for Evaluation and Treatment of Erectile Dysfunction

Joel J Wackerbarth et al. Sex Med. 2021 Feb.

Abstract

Background: Direct-to-consumer (DTC) Internet-based prescription and pharmacy platforms offer electronic consultation for evaluation and pharmacologic treatment of erectile dysfunction (ED) without a physical exam or in-person visit, presenting a potentially dramatic shift in care for this condition.

Aim: To characterize the extent to which DTC prescribing sites for ED generate traffic and attract individual users.

Methods: Using SEMRush, a marketing software platform that provides analytics regarding website traffic, we examined online site visits to 6 major DTC prescribing websites offering ED evaluation and treatment from October 2017 through December 2019.

Outcomes: We recorded trends in the number of unique visitors over time, visitor referral patterns, and the proportion of overall visitors to individual sites.

Results: During the study period, the total number of unique, quarterly visitors increased by 1,688% from 655,733 in the 4th quarter (Q4) 2017 to over 11 million in Q4 2019. In 2019, there were on average 4,971,674 visits to all sites combined each month. For the 2 largest sites (Hims and Roman), visitors predominantly reached the site via direct web address (27.3%) or search engine referral (27.3%).

Clinical implications: An increasingly large number of potential patients are utilizing DTC prescribing platforms for the diagnosis and treatment of ED, which do not require physical exams or treatment of other comorbid conditions.

Strength & limitations: Demonstrates high demand for ED DTC prescribing services using independent market research software and characterizes the number of visits for the first time. Limitations include the lack of individual demographics and lack of information regarding what proportion of unique visits lead to evaluation and treatment using the services.

Conclusion: The dramatic increase in visits to DTC prescribing sites that treat ED represents a paradigm shift in ED care, and it is imperative that clinicians and researchers work to understand how patients utilize online telemedicine, the safety and efficacy of online management of ED, and the potential downstream implications of its widespread use. Wackerbarth JJ, Fantus RJ, Darves-Bornoz A, et al. Examining Online Traffic Patterns to Popular Direct-To-Consumer Websites for Evaluation and Treatment of Erectile Dysfunction. Sex Med 2021;9:100289.

Keywords: Erectile Dysfunction; Men’s Health; Telemedicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trends in monthly website traffic to major direct-to-consumer Internet-based prescription platform providers. The trend in Google relative search volume for the term “erectile dysfunction” is presented as a comparison.
Figure 2
Figure 2
Unique visitors to each individual site by quarter.
See this image and copyright information in PMC

Comment in

References

    1. Feldman H.A., Goldstein I., Hatzichristou D.G. Impotence and its medical and Psychosocial Correlates: results of the Massachusetts Male Aging study. J Urol. 1994;151:54–61. - PubMed
    1. Selvin E., Burnett A.L., Platz E.A. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–157. - PubMed
    1. Heidler S., Temml C., Broessner C. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol. 2007;177:651–654. - PubMed
    1. Shin D., Pregenzer G., Gardin J.M. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19:5–11. - PubMed
    1. Melman A., Gingell J.C. The epidemiology and pathophysiology of erectile dysfuntion. J Urol. 1999;161:5–11. - PubMed